Drosophila Contributions towards Understanding Neurofibromatosis 1
- PMID: 38667335
- PMCID: PMC11048932
- DOI: 10.3390/cells13080721
Drosophila Contributions towards Understanding Neurofibromatosis 1
Abstract
Neurofibromatosis 1 (NF1) is a multisymptomatic disorder with highly variable presentations, which include short stature, susceptibility to formation of the characteristic benign tumors known as neurofibromas, intense freckling and skin discoloration, and cognitive deficits, which characterize most children with the condition. Attention deficits and Autism Spectrum manifestations augment the compromised learning presented by most patients, leading to behavioral problems and school failure, while fragmented sleep contributes to chronic fatigue and poor quality of life. Neurofibromin (Nf1) is present ubiquitously during human development and postnatally in most neuronal, oligodendrocyte, and Schwann cells. Evidence largely from animal models including Drosophila suggests that the symptomatic variability may reflect distinct cell-type-specific functions of the protein, which emerge upon its loss, or mutations affecting the different functional domains of the protein. This review summarizes the contributions of Drosophila in modeling multiple NF1 manifestations, addressing hypotheses regarding the cell-type-specific functions of the protein and exploring the molecular pathways affected upon loss of the highly conserved fly homolog dNf1. Collectively, work in this model not only has efficiently and expediently modelled multiple aspects of the condition and increased understanding of its behavioral manifestations, but also has led to pharmaceutical strategies towards their amelioration.
Keywords: Drosophila; Neurofibromatosis 1; animal models; behavioral deficits; growth.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11048932/bin/cells-13-00721-g001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11048932/bin/cells-13-00721-g002a.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11048932/bin/cells-13-00721-g002a.gif)
Similar articles
-
Neurofibromin Loss of Function Drives Excessive Grooming in Drosophila.G3 (Bethesda). 2016 Apr 7;6(4):1083-93. doi: 10.1534/g3.115.026484. G3 (Bethesda). 2016. PMID: 26896440 Free PMC article.
-
Neurofibromatosis 1: closing the GAP between mice and men.Curr Opin Genet Dev. 2003 Feb;13(1):20-7. doi: 10.1016/s0959-437x(02)00015-1. Curr Opin Genet Dev. 2003. PMID: 12573431 Review.
-
New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.Genes (Basel). 2020 Apr 28;11(5):477. doi: 10.3390/genes11050477. Genes (Basel). 2020. PMID: 32353955 Free PMC article. Review.
-
A porcine model of neurofibromatosis type 1 that mimics the human disease.JCI Insight. 2018 Jun 21;3(12):e120402. doi: 10.1172/jci.insight.120402. eCollection 2018 Jun 21. JCI Insight. 2018. PMID: 29925695 Free PMC article.
-
S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas.J Neurosci Res. 2011 Sep;89(9):1451-60. doi: 10.1002/jnr.22654. Epub 2011 Jun 14. J Neurosci Res. 2011. PMID: 21674567
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous